Simplified protocol for flow cytometry analysis of fluorescently labeled exosomes and microvesicles using dedicated flow cytometer
暂无分享,去创建一个
Jan Svoboda | Ladislav Ilkovics | Zankruti Dave | Ales Hampl | A. Hampl | V. Bryja | I. Crha | Vendula Pospichalova | Anna Kotrbova | Karol Kaiser | Dobromila Klemova | Igor Crha | Eva Jandakova | Lubos Minar | Vit Weinberger | Vitezslav Bryja | V. Weinberger | L. Minar | E. Jandáková | V. Pospíchalová | J. Svoboda | Zankruti Dave | Ladislav Ilkovics | Dobromila Klemová | A. Kotrbová | Karol Kaiser | L. Minář | Vendula Pospíchalová
[1] Chris Gardiner,et al. Extracellular vesicle sizing and enumeration by nanoparticle tracking analysis , 2013, Journal of extracellular vesicles.
[2] Graça Raposo,et al. The Biogenesis and Functions of Exosomes , 2002, Traffic.
[3] O. C. Blair,et al. Practical Flow Cytometry , 1985, The Yale Journal of Biology and Medicine.
[4] R Lacroix,et al. Standardization of platelet‐derived microparticle enumeration by flow cytometry with calibrated beads: results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop , 2010, Journal of thrombosis and haemostasis : JTH.
[5] M. V. van Gemert,et al. Single vs. swarm detection of microparticles and exosomes by flow cytometry , 2012, Journal of thrombosis and haemostasis : JTH.
[6] C. Théry,et al. Membrane vesicles as conveyors of immune responses , 2009, Nature Reviews Immunology.
[7] V. Subramaniam,et al. Refractive index sensing of green fluorescent proteins in living cells using fluorescence lifetime imaging microscopy. , 2008, Biophysical journal.
[8] T G van Leeuwen,et al. Optical and non‐optical methods for detection and characterization of microparticles and exosomes , 2010, Journal of thrombosis and haemostasis : JTH.
[9] Willem Stoorvogel,et al. Fluorescent labeling of nano-sized vesicles released by cells and subsequent quantitative and qualitative analysis by high-resolution flow cytometry , 2012, Nature Protocols.
[10] N. Vitale,et al. Syntenin-ALIX exosome biogenesis and budding into multivesicular bodies are controlled by ARF6 and PLD2 , 2014, Nature Communications.
[11] Paul J. Harrison,et al. Sizing and phenotyping of cellular vesicles using Nanoparticle Tracking Analysis , 2011, Nanomedicine : nanotechnology, biology, and medicine.
[12] G. Kristiansen,et al. Malignant ascites-derived exosomes of ovarian carcinoma patients contain CD24 and EpCAM. , 2007, Gynecologic oncology.
[13] J. Tait,et al. A new microparticle size calibration standard for use in measuring smaller microparticles using a new flow cytometer , 2011, Journal of thrombosis and haemostasis : JTH.
[14] S. Kaye,et al. Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research , 2013, Nature Reviews Cancer.
[15] Ger J.A. Arkesteijn,et al. Quantitative and qualitative flow cytometric analysis of nanosized cell-derived membrane vesicles , 2011, Nanomedicine: Nanotechnology, Biology and Medicine.
[16] E. Orenes-Piñero,et al. An innovative flow cytometric approach for small-size platelet microparticles: Influence of calcium , 2012, Thrombosis and Haemostasis.
[17] Winston Patrick Kuo,et al. Current methods for the isolation of extracellular vesicles , 2013, Biological chemistry.
[18] Andrew F. Hill,et al. Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles , 2014, Journal of extracellular vesicles.
[19] H. Shapiro. Practical Flow Cytometry: Shapiro/Flow Cytometry 4e , 2005 .
[20] C. Parish,et al. New fluorescent dyes for lymphocyte migration studies. Analysis by flow cytometry and fluorescence microscopy. , 1990, Journal of immunological methods.
[21] Lynne T. Bemis,et al. Standardization of sample collection, isolation and analysis methods in extracellular vesicle research , 2013, Journal of extracellular vesicles.
[22] H. Hilton,et al. The multifaceted exosome: Biogenesis, role in normal and aberrant cellular function, and frontiers for pharmacological and biomarker opportunities , 2011, Biochemical Pharmacology.
[23] S. Mathivanan,et al. ExoCarta: A compendium of exosomal proteins and RNA , 2009, Proteomics.
[24] G. Schulte,et al. Wnt-3a utilizes a novel low dose and rapid pathway that does not require casein kinase 1-mediated phosphorylation of Dvl to activate beta-catenin. , 2007, Cellular signalling.
[25] C. Théry,et al. Exosomes and communication between tumours and the immune system: are all exosomes equal? , 2013, Biochemical Society transactions.
[26] Stefano Fais,et al. Exosomes: the future of biomarkers in medicine. , 2013, Biomarkers in medicine.
[27] Graça Raposo,et al. Extracellular vesicles: Exosomes, microvesicles, and friends , 2013, The Journal of cell biology.
[28] I. Sargent,et al. Particle size distribution of exosomes and microvesicles determined by transmission electron microscopy, flow cytometry, nanoparticle tracking analysis, and resistive pulse sensing , 2014, Journal of thrombosis and haemostasis : JTH.
[29] P. Barber. Absorption and scattering of light by small particles , 1984 .
[30] A. B. Lyons,et al. Divided we stand: Tracking cell proliferation with carboxyfluorescein diacetate succinimidyl ester , 1999, Immunology and cell biology.
[31] J. Le Pecq,et al. Production and characterization of clinical grade exosomes derived from dendritic cells. , 2002, Journal of immunological methods.
[32] Melinda Fitzgerald,et al. Immunol. Cell Biol. , 1995 .
[33] Meg Duroux,et al. A comprehensive overview of exosomes as drug delivery vehicles - endogenous nanocarriers for targeted cancer therapy. , 2014, Biochimica et biophysica acta.
[34] Aled Clayton,et al. Isolation and Characterization of Exosomes from Cell Culture Supernatants and Biological Fluids , 2006, Current protocols in cell biology.